Table 2.
Study | Year | Follow Up (m) | Total AF Patients | AF Patient With ICD | AF Patients on Med Therapy | Age (y) | Male (%) | ICD Indication | LVEF (%) | Use of AA (%) | NYHA Class (%) | Quality Assessmenta |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Zareba et al15 | 2006 | 20 | 102 | 61 | 41 | 65 | NA | Unspecified | ··· | 14 | 2 to 4:73 | Good |
Singh et al28 | 2006 | 29 | 173 | 65 | 108 | 64 | 91 | Unspecified | 25 | 37 | <3: 60, ≥3: 40 | Good |
Kadish et al29 | 2004 | 45.5 | 112 | 52 | 60 | 58 | NA | SP | 21 | 5.2 | <3: 79, ≥3: 21 | ··· |
AA indicates antiarrhythmic; AF, atrial fibrillation; ICD, implantable cardioverter‐defibrillator; LVEF, left ventricular ejection fraction; Med therapy, goal‐directed medical therapy; SP, secondary prevention.
Newcastle–Ottawa Quality Assessment Scale: poor <4, fair 5 to 6, good >7.